Literature DB >> 27175261

Harnessing alloreactivity to achieve anti-leukemic responses.

L D Fast1.   

Abstract

Entities:  

Keywords:  alloreactive cells; alloreactive responses; cytolytic effector molecules; donor lymphocyte infusions; leukemia reactive cells

Year:  2014        PMID： 27175261      PMCID： PMC4851287          DOI： 10.1038/leusup.2014.6

Source DB:  PubMed          Journal:  Leuk Suppl        ISSN： 2044-5210


× No keyword cloud information.
  7 in total

Review 1.  Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications.

Authors:  L J D'Orsogna; T H O Nguyen; F H J Claas; C Witt; N A Mifsud
Journal:  Tissue Antigens       Date:  2013-06

2.  Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

Authors:  P L Weiden; N Flournoy; E D Thomas; R Prentice; A Fefer; C D Buckner; R Storb
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

3.  Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease.

Authors:  Gerald P Morris; Geoffrey L Uy; David Donermeyer; John F Dipersio; Paul M Allen
Journal:  Sci Transl Med       Date:  2013-06-05       Impact factor: 17.956

4.  Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism.

Authors:  Gerald A Colvin; David Berz; Muthalagu Ramanathan; Eric S Winer; Loren Fast; Gerald J Elfenbein; Peter J Quesenberry
Journal:  Biol Blood Marrow Transplant       Date:  2009-04       Impact factor: 5.742

Review 5.  Graft-versus-leukemia effects of transplantation and donor lymphocytes.

Authors:  Hans-Jochem Kolb
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

6.  Immune evasion in acute myeloid leukemia: current concepts and future directions.

Authors:  Ryan M Teague; Justin Kline
Journal:  J Immunother Cancer       Date:  2013-08-27       Impact factor: 13.751

7.  Cellular immunotherapy for refractory hematological malignancies.

Authors:  John L Reagan; Loren D Fast; Howard Safran; Martha Nevola; Eric S Winer; Jorge J Castillo; James N Butera; Matthew I Quesenberry; Carolyn T Young; Peter J Quesenberry
Journal:  J Transl Med       Date:  2013-06-19       Impact factor: 5.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.